Leaving aside the share price action.
The company is at the inflection point. This space is hot and we appear to have a very promising technology within it.
But things move quickly in oncology. What is hot this year is out the next when the next big thing arrives.
I’m not qualified to determine the true value of Clarity. You would need total visibility on the market with insider info on what is coming down the pipe within the research establishments.
But my spider senses tell me now is probably the right time to sell the company.
CU6 - General discussion, page-331
-
- There are more pages in this discussion • 153 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.35 |
Change
0.200(2.80%) |
Mkt cap ! $2.353B | |||
| Open | High | Low | Value | Volume |
| $7.22 | $7.58 | $7.17 | $8.142M | 1.098M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3007 | $7.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.35 | 2304 | 1 |
View Market Depth
| Last trade - 16.10pm 06/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |